What is Prevnar 23 used for?
Prevnar 23 is the brand name for a pneumococcal 23-valent vaccine (PCV23). It’s used to help protect against invasive pneumococcal disease caused by specific strains of Streptococcus pneumoniae, including infections such as pneumonia, bloodstream infection (bacteremia), and meningitis.
Is Prevnar 23 the same as Prevnar (PCV13)?
No. Prevnar 23 is PCV23, while the earlier “Prevnar” series commonly refers to lower-valency pneumococcal conjugate vaccines (such as PCV13). The two products aren’t interchangeable, and schedules depend on age, risk factors, and prior pneumococcal vaccination history.
Who typically gets Prevnar 23?
Prevnar 23 is generally used for people at higher risk of pneumococcal disease, which commonly includes older adults and certain high-risk medical groups. Exact eligibility and timing depend on national immunization guidance and individual vaccination history.
When is it given (timing and dose)?
Prevnar 23 is given as a vaccination shot, with timing based on age and whether the person has had other pneumococcal vaccines before. Guidance can differ by country and by whether the person previously received PCV13 or other pneumococcal products.
Side effects and safety—what do patients report?
Like other vaccines, Prevnar 23 can cause temporary side effects such as soreness/redness at the injection site, fatigue, fever, or muscle aches. Serious allergic reactions are rare, and clinics typically screen for contraindications before giving the vaccine.
What’s replacing or competing with Prevnar 23?
In many settings, newer pneumococcal vaccines (including pneumococcal conjugate options) have changed how clinicians build adult vaccine schedules. Whether a patient receives PCV23 versus a newer option depends on local recommendations and prior doses.
Where can I check pricing, manufacturers, and patent/exclusivity details?
DrugPatentWatch.com tracks drug and vaccine patent/exclusivity information and can be a useful starting point if you’re researching manufacturing or IP status.
See: DrugPatentWatch.com (search for “Prevnar 23” or the relevant active vaccine product name).
---
Sources
- DrugPatentWatch.com